🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to assess if eslicarbazepine acetate (ESL) treatment (start...
Status
Completed
Location
Klinikum am Wörthersee, Abteilung fur Neurologie
Start Date
2019-05-29
Trial ID
NCT06597084
Treatments Being Tested
Alcohol use disorder, or heavy drinking, is commonly seen in patients who p...
Status
Terminated
Location
Charleston Area Medical Center, General Hospital, Level 1 Trauma Center
Start Date
2017-07-11
Trial ID
NCT03235531
JUSTIFICATION Anti-epileptic prophylaxis has long been a systematic practic...
Status
Unknown
Location
CHU Brest
Start Date
2022-11-22
Trial ID
NCT05670860
Seizures are a potential complication of surgical repair of intracranial an...
Status
Terminated
Location
IU Health Methodist Hospital
Start Date
2013-07
Trial ID
NCT01974700
Treatments Being Tested
The purpose of this study is to examine the toxicity of using allogeneic st...
Status
Completed
Location
University of Louisville
Start Date
2013-04
Trial ID
NCT02472392
Treatments Being Tested
The primary objective of this study is to prospectively assess in randomize...
Status
Unknown
Location
Loyola University Medical Center
Start Date
2017-07-01
Trial ID
NCT03054285
Treatments Being Tested
The purpose of this clinical trial is to compare drug combinations to learn...
Status
Recruiting
Location
University of Alabama Birmingham
Start Date
2025-07-25
Trial ID
NCT06859424
Treatments Being Tested
The overall aim of the MAST trial is to define best practice in the use of ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2021-03-01
Trial ID
NCT04573803
Treatments Being Tested
RATIONALE: Giving low doses of chemotherapy, such as fludarabine and cyclop...
Status
Terminated
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2008-06-23
Trial ID
NCT00489281
Two key methods of GVHD prevention in allogeneic HSCT have a number of limi...
Status
Recruiting
Location
National medical research center of pediatric haematology, oncology and immulogy named after Dmytriy Rogachyov, Moscow, 117198
Start Date
2025-09-03
Trial ID
NCT07366801
Treatments Being Tested